Insulin resistance contributes to hyperinsulinemia, which enhances tumorigenesis by activating insulin-like growth factor 1 (IGF-1) signaling, a pathway that promotes cell proliferation and inhibits apoptosis. Here, IGF1 is linked to hyperinsulinism.